
Vibcare Pharma
05/10/26
| Type | Example ingredients | How it is regulated |
|---|---|---|
| Allopathic combinations | Silymarin, L-ornithine L-aspartate (LOLA), B vitamins | Drugs (CDSCO / state drug licence) |
| Ayurvedic proprietary medicines | Bhumi amla, kasni, punarnava, bhringraj, kalmegh, kutki | Ayurvedic drug licence (Drugs and Cosmetics Act, Chapter IVA) |
| Health supplements | Varies by product | FSSAI — may not claim to treat disease; label must say "HEALTH SUPPLEMENT" and "NOT FOR MEDICINAL USE" |
| Prescription liver medicines | Ursodeoxycholic acid (UDCA), LOLA injection | Sold on prescription, for diagnosed conditions |
"Liver tonic" is a trade expression, not a drug class. A product sold as a "liver syrup" or "liver tonic" can be an ayurvedic medicine, an allopathic syrup containing silymarin or L-ornithine L-aspartate, or a food-grade health supplement, and each follows its own rules. Prescription liver medicines are a separate group again: they are dispensed only against a doctor's prescription.
These are sold as drugs. Common ingredients are silymarin (an extract of milk thistle), L-ornithine L-aspartate (LOLA) and a group of B vitamins such as pyridoxine, niacinamide, vitamin B12, thiamine and riboflavin. Some tablets, such as Hepamerz, add pancreatin, a digestive enzyme preparation, to LOLA. Check the label for prescription status: prescription medicines must be taken only as prescribed by a doctor.
These come under the ayurvedic provisions of the Drugs and Cosmetics Act (Chapter IVA), and Rule 161 requires the label to say "Ayurvedic medicine". Typical ingredients are bhumi amla (Phyllanthus species), kasni (chicory), punarnava, bhringraj, kalmegh, kutki, kakamachi, himsra, guduchi, daruhaldi, makoy and yashtimadhu. Himalaya's Liv.52 tablet is described by the company itself as an "Ayurvedic proprietary medicine", and the Liv.52 syrup lists himsra, kasani, kakamachi, arjuna, kasamarda and biranjasipha among its ingredients.
These are regulated as food by FSSAI, not as drugs. Because they are foods, their labels and advertisements may not say that the product prevents, treats or cures a disease, and the label has to carry the words "HEALTH SUPPLEMENT" and "NOT FOR MEDICINAL USE". Under the FSSAI rules, a product that makes a disease claim is a drug, not a health supplement.
These are medicines for specific, diagnosed conditions, sold on a doctor's prescription. Ursodeoxycholic acid (UDCA) tablets such as Udiliv are one example. They are not tonics. Prescription medicines must be taken only as prescribed by a doctor.
For the main ingredients reviewed below, the published evidence is limited or conflicting. Ursodeoxycholic acid is different: it is a prescription medicine with specific listed uses. Here is what the reviews found.
Silymarin is sold in India in tablets and in combination syrups. The US National Center for Complementary and Integrative Health (NCCIH, updated February 2025) says there is not enough high-quality evidence to know whether milk thistle helps with liver disease: trials have been conflicting or too limited, and two studies funded by NCCIH itself found no benefit.
The 2007 Cochrane review of 13 trials in 915 patients with alcoholic and/or hepatitis B or C liver disease found no significant effect of milk thistle on mortality or on liver complications in the high-quality trials. NCCIH reports that milk thistle is usually well tolerated, with bloating, nausea and gas among the side effects noted.
LOLA is sold in India in tablets, syrups and injections. A Cochrane review of LOLA for hepatic encephalopathy in people with cirrhosis (2018) found a possible benefit across all the trials pooled together, but not when the analysis was limited to trials at low risk of bias; the certainty of the evidence was rated very low, and there was no extra benefit over lactulose or rifaximin.
The joint EASL/AASLD guideline on hepatic encephalopathy states plainly that "oral supplementation with LOLA is ineffective", that lactulose is the first-choice treatment, and that intravenous LOLA "can be used as an alternative or additional agent" for patients who do not respond to conventional therapy. In short, the guideline gives the intravenous form a limited role for patients who do not respond to standard treatment, and does not support the oral form for hepatic encephalopathy.
Bhumi amla (Phyllanthus) is an ingredient in several ayurvedic liver syrups. The Cochrane review of Phyllanthus species for chronic hepatitis B virus infection (2022) found no convincing evidence of benefit over placebo; all 16 trials included were judged to be at high risk of bias. The review looked only at chronic hepatitis B.
The published trial record for Liv.52 is weak and mixed. A 2003 double-blind trial in Sri Lanka in 80 patients with alcoholic liver disease, reported in the Journal of Ethnopharmacology, found no significant difference from placebo over six months. A 2025 meta-analysis of 10 trials (758 patients) found possible benefits in a few measures, such as appetite and one liver enzyme (SGPT), but not in most, and rated the quality of the evidence from very low to moderate.
UDCA is a medicine with specific listed uses, not a tonic. The UK summary of product characteristics for Ursofalk lists its indications as primary biliary cholangitis, the dissolution of radiolucent gallstones, and hepatobiliary disease in cystic fibrosis; it also warns that aluminium-containing antacids should not be taken at the same time. In India, UDCA tablets such as Udiliv are sold on prescription, and prescription medicines must be taken only as prescribed by a doctor.
Some Indian liver syrups list tricholine citrate as an ingredient. When we searched PubMed in October 2026, we found no clinical trial of tricholine citrate in liver disease.
Herbal and dietary supplement products can themselves cause liver injury, and in India adulteration and heavy-metal contamination are documented causes. A 2020 review in the World Journal of Hepatology reported that ayurvedic medicines caused drug-induced liver injury in about 1.3% of the patients studied and that almost half of those cases were fatal; the causes listed include herb toxicity, interactions with other drugs, adulteration with prescription drugs and heavy-metal contamination.
The same problem is seen elsewhere. In the United States, herbal and dietary supplements were responsible for 20% of drug-induced liver injury cases in 2013–14, up from 7% in 2004–05. "Natural" does not automatically mean safe: choose licensed products whose label names the manufacturer and lists every ingredient, and tell your doctor about any herbal product you take.
The NHS says the aim of treatment for alcohol-related liver disease is usually to help you stop drinking alcohol completely. It also warns that if you regularly drink too much, it can be very dangerous to stop suddenly, so get medical help before you try to stop.
The NHS says most types of liver disease do not cause any symptoms in the early stages. Later symptoms can include:
See a doctor if you think you might have liver disease. A tonic does not replace a diagnosis, and prescription medicines must be taken only as prescribed by a doctor.
Indian law forbids any drug from claiming to prevent or cure jaundice, hepatitis or any liver disorder, because these are listed in Schedule J of the Drugs Rules. Rule 106 of the Drugs Rules lays down the advertisement restrictions, and Schedule J lists the diseases that no drug may claim to prevent or cure; the entry covers "Jaundice/Hepatitis/Liver disorders" and applies to allopathic as well as ayurvedic products.
For buyers, the label tells you more than a slogan: check the licence category (drug, ayurvedic medicine or health supplement) and the full ingredient list.
The liver products below are listed by Himalaya and Indian online pharmacies, with their stated composition and category only; no health claim is made for any of them here. Prescription items must be taken only as prescribed by a doctor.
| Product | Stated composition | Category |
|---|---|---|
| Liv.52 (Himalaya) | Tablet described by the company as an "Ayurvedic proprietary medicine"; syrup ingredients include himsra, kasani, kakamachi, arjuna, kasamarda and biranjasipha | Ayurvedic proprietary medicine |
| Silybon-140 (Micro Labs) | Silymarin 140 mg | Prescription drug |
| Udiliv 600 (Abbott India) | Ursodeoxycholic acid | Prescription drug |
| Hepamerz tablet | L-ornithine L-aspartate 150 mg + pancreatin 100 mg | Prescription drug |
Vibcare Pharma markets 16 liver-related products across five divisions. They are described here by composition only, with no health claim made for any item; compositions, packs and MRPs are as stated on our product pages. For use, dose and warnings, read the pack label and follow your doctor's advice.
4 divisions
Prima
Nuralz
Evermed
4 divisions
Prescription medicines must be taken only as prescribed by a doctor. Vibcare Pharma Pvt Ltd, incorporated in 2014 with commercial operations from 2015, appoints PCD franchise partners district by district, with one partner per district and monopoly rights confirmed in writing. The manufacturing company, Vibcare Healthcare, owns a WHO-GMP plant at Panchkula, and injectables, ophthalmics and the NURALZ ayurvedic range are made at partner WHO-GMP units with the manufacturer named on the pack. To start a franchise you need a wholesale drug licence and GST registration.
Add liver and ayurvedic products to your range
Vibcare appoints one PCD franchise partner per district, with monopoly rights confirmed in writing. Trade rates for every product are on its product page.
"Liver tonic" is a market label used in India for syrups, tablets and drops sold around liver health; it is not a recognised medical or pharmacological category. Products sold under this name range from ayurvedic medicines and allopathic combinations to food-grade supplements, and none of them may claim to prevent or cure jaundice, hepatitis or any liver disorder under Indian rules. Whether any of them suits you is for your doctor to decide, based on your diagnosis.
For the main ingredients reviewed here, the good-quality clinical evidence is limited or conflicting. Cochrane reviews found no significant benefit for milk thistle in alcoholic and hepatitis B or C liver disease, no convincing benefit for Phyllanthus in chronic hepatitis B, and only very low-certainty evidence for L-ornithine L-aspartate in hepatic encephalopathy; an international guideline states that oral LOLA is ineffective. Ursodeoxycholic acid has specific listed uses (UK Ursofalk label), but those are diagnosed conditions treated on prescription, not general tonic use.
It is not known. The US National Center for Complementary and Integrative Health states that there is not enough high-quality evidence to determine whether milk thistle helps with liver disease, and two NCCIH-funded studies found no benefit. It is usually well tolerated, with bloating, nausea and gas reported. If you have a liver condition, ask your doctor before adding any product.
Yes. A 2020 review in the World Journal of Hepatology reported that ayurvedic medicines caused drug-induced liver injury in about 1.3% of the patients studied, with almost half of those cases fatal, and listed herb toxicity, drug interactions, adulteration with prescription drugs and heavy-metal contamination as causes. In the United States, herbal and dietary supplements accounted for 20% of drug-induced liver injury cases in 2013–14, up from 7% a decade earlier. Tell your doctor about any herbal product you take, and see a doctor if your skin or the whites of your eyes turn yellow.
Talk to your doctor before taking any product for your liver. The NHS says the aim of treatment for alcohol-related liver disease is usually to help you stop drinking alcohol completely, and warns that stopping suddenly after regular heavy drinking can be very dangerous, so get medical help before you try to stop.
Yes. Himalaya describes the Liv.52 tablet as an "Ayurvedic proprietary medicine", and the Liv.52 syrup lists himsra, kasani, kakamachi, arjuna, kasamarda and biranjasipha among its ingredients. Published trial results for it are weak and mixed, and Indian rules do not allow any such product to claim that it prevents or cures jaundice, hepatitis or any liver disorder.
See a doctor if you think you might have liver disease. The NHS says most liver disease causes no symptoms early on, and lists later symptoms such as feeling very tired and weak, loss of appetite and weight loss, yellow skin and whites of the eyes (jaundice), itchy skin, and feeling or being sick. Prescription medicines must be taken only as prescribed by a doctor.
Add liver and ayurvedic products to your range
Vibcare appoints one PCD franchise partner per district, with monopoly rights confirmed in writing. Trade rates for every product are on its product page.
Copy Link